Just released in the New Zealand Herald and formally published at the New Zealand Dermatological Society, the phase 3 trial for Honevo for acne shows promising results for spots and pimples which affects most people at some stage of their lives.


HoneyLab has another product on the market (www.honevo.co.nz) and will be presenting these results to potential licensees in the coming weeks.